Specifically, in Black adults with HTN, when a renin-angiotensin system modulator is required, an angiotensin receptor blocker (ARB) may be preferred over an angiotensin-converting enzyme (ACE) inhibitor. The gene discussed is ACE; the disease is hypertensive disorder.